Views: 1,463 | Downloads:
22
| Responses: 0
| XML | Respond to this article | Alert & updates | Request permissions | Email to a friend |
Original ArticleOpen Access
Dose-Expanded Study in the Reinforcement of Efficacy of Simvastatin
Vichayanrat A 
Two hundred and twenty two hyperlipidemic patients were recruited for a 12-week pro-
spective, multicenter, open-label, titrate-to-goal study to evaluate the efficacy and safety of 20 to
40 mg per day of simvastatin in a Thai population. The efficacy on lipid lowering was evaluated
at 4 weeks and 8 weeks after medication. Based on NCEP A TP II guideline and ADA position
statement, subjects were categorized into three groups according to LDL-C goals; group 1: patients
without CHD and with
spective, multicenter, open-label, titrate-to-goal study to evaluate the efficacy and safety of 20 to
40 mg per day of simvastatin in a Thai population. The efficacy on lipid lowering was evaluated
at 4 weeks and 8 weeks after medication. Based on NCEP A TP II guideline and ADA position
statement, subjects were categorized into three groups according to LDL-C goals; group 1: patients
without CHD and with
Download:
PDF